IOL Chemicals and Pharmaceuticals Limited (NSE:IOLCP)

NSE:IOLCP Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	1,265	653.5	781.7	76.9	13.9	32.3
Short-Term Investments	36.6	1,347	1,308	1,348	170.2	1,163
Trading Asset Securities	-	3	3.1	2.9	2.3	2.2
Cash & Short-Term Investments	1,301	2,003	2,093	1,428	186.4	1,197
Cash Growth	-24.24%	-4.29%	46.60%	665.88%	-84.43%	-64.43%
Accounts Receivable	6,892	6,031	5,137	4,712	5,053	4,698
Other Receivables	-	188.2	193.7	176.4	231.5	231.2
Receivables	6,892	6,220	5,331	4,899	5,292	4,934
Inventory	4,644	3,711	3,606	4,248	3,255	4,099
Prepaid Expenses	-	92.6	78.8	134.2	82	78.9
Other Current Assets	825.4	250.5	404.9	489	388.7	499.4
Total Current Assets	13,662	12,276	11,513	11,198	9,204	10,808
Property, Plant & Equipment	13,670	12,624	11,792	10,214	8,326	6,625
Long-Term Investments	603.6	611.2	250.5	657.5	2,482	2,037
Other Intangible Assets	132.3	147.1	134.6	126.1	88.9	33.5
Other Long-Term Assets	238	210.9	130.4	248.8	121.4	119.3
Total Assets	28,306	25,870	23,821	22,444	20,221	19,623

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	4,878	4,826	4,276	4,692	3,142	4,093
Accrued Expenses	49.6	133.1	109.2	110.4	152.3	143.3
Short-Term Debt	1,942	1,320	1,170	327.6	796.3	427.5
Current Portion of Leases	16.8	10.2	-	-	1.8	10.2
Current Income Taxes Payable	124.7	23.5	-	-	-	-
Current Unearned Revenue	-	-	0.4	1	1.1	3.6
Other Current Liabilities	1,003	589.4	543.5	469.2	468.9	456.5
Total Current Liabilities	8,013	6,902	6,099	5,600	4,563	5,134
Long-Term Leases	54.2	24	-	-	-	1.8
Long-Term Unearned Revenue	-	-	-	0.4	1.4	2.5
Pension & Post-Retirement Benefits	-	84.8	47.3	54.4	1.3	10.7
Long-Term Deferred Tax Liabilities	859.5	848.6	778.1	661.4	563.6	531.8
Other Long-Term Liabilities	122.8	24.8	19.6	12.7	15.2	19.4
Total Liabilities	9,050	7,884	6,944	6,329	5,144	5,700

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	587.1	587.1	587.1	587.1	587.1	587.1
Additional Paid-In Capital	-	2,257	2,257	2,257	2,257	2,257
Retained Earnings	-	15,104	14,021	13,245	12,194	11,038
Comprehensive Income & Other	18,669	37.6	11.6	26	38.9	40.9
Shareholders' Equity	19,257	17,986	16,877	16,115	15,077	13,923
Total Liabilities & Equity	28,306	25,870	23,821	22,444	20,221	19,623

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	2,013	1,354	1,170	327.6	798.1	439.5
Net Cash (Debt)	-711.4	648.8	922.5	1,100	-611.7	757.8
Net Cash Growth	-	-29.67%	-16.14%	-	-	-77.30%
Net Cash Per Share	-2.42	2.21	3.14	3.75	-2.08	2.58
Filing Date Shares Outstanding	293.11	293.53	293.53	293.53	293.53	293.53
Total Common Shares Outstanding	293.11	293.53	293.53	293.53	293.53	293.53
Working Capital	5,649	5,375	5,414	5,598	4,641	5,674
Book Value Per Share	65.70	61.27	57.50	54.90	51.37	47.43
Tangible Book Value	19,124	17,838	16,742	15,989	14,988	13,889
Tangible Book Value Per Share	65.25	60.77	57.04	54.47	51.06	47.32
Land	-	1,606	1,601	1,412	704.4	560.7
Buildings	-	2,221	2,113	1,487	1,369	1,001
Machinery	-	12,275	11,566	9,320	7,848	6,034
Construction In Progress	-	936.1	208.1	998.3	814	1,020

Data Source: S&P Global Market Intelligence Last updated: Oct 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 10, 2026

Data Sources Report a data error